AIM AND SCOPE

The Annals of Gastroenterology, Liver & Pancreatic Diseases aims to serve as a comprehensive international platform for the publication of high-quality research, clinical studies, and scholarly contributions in the fields of gastroenterology, hepatology, pancreatology, and digestive health sciences. The journal is dedicated to advancing scientific understanding of gastrointestinal, liver, biliary, and pancreatic diseases, improving diagnostic and therapeutic methodologies, and promoting innovative clinical and translational research that enhances patient care and healthcare outcomes.

The journal seeks to bridge the gap between basic science and clinical practice by encouraging interdisciplinary and translational studies related to the prevention, diagnosis, management, and treatment of digestive system disorders. It aims to support evidence-based medicine, precision healthcare, and emerging therapeutic technologies that contribute to improved disease management and quality of life.

The journal also promotes collaboration among gastroenterologists, hepatologists, pancreatic specialists, surgeons, pathologists, researchers, academicians, nutritionists, and healthcare professionals worldwide. Emphasis is placed on scientific rigor, ethical research practices, clinical relevance, and the dissemination of findings with meaningful scientific and societal impact.

Scope of the Journal

The journal covers a broad range of topics related to gastroenterology, liver diseases, pancreatic disorders, digestive sciences, and associated therapeutic research. The primary areas of interest include, but are not limited to, the following:

General gastroenterology, clinical gastroenterology, digestive diseases, gastrointestinal physiology, gastrointestinal pathology, gastrointestinal pharmacology, gastrointestinal microbiology, gastrointestinal immunology, inflammatory bowel disease, Crohn’s disease, ulcerative colitis, irritable bowel syndrome, functional gastrointestinal disorders, gastrointestinal infections, celiac disease, peptic ulcer disease, gastroesophageal reflux disease, Barrett’s esophagus, esophageal disorders, gastric disorders, intestinal disorders, colorectal diseases, anorectal disorders, gastrointestinal bleeding, malabsorption syndromes, motility disorders, gastrointestinal oncology, colorectal cancer, gastric cancer, esophageal cancer, pancreatic cancer, hepatobiliary cancers, neuroendocrine tumors, gastrointestinal stromal tumors, liver diseases, hepatology, viral hepatitis, hepatitis A, hepatitis B, hepatitis C, hepatitis E, autoimmune liver diseases, alcoholic liver disease, non-alcoholic fatty liver disease, metabolic-associated fatty liver disease, cirrhosis, portal hypertension, hepatic fibrosis, liver failure, liver transplantation, biliary diseases, gallbladder disorders, cholangitis, cholestatic liver diseases, pancreatic diseases, acute pancreatitis, chronic pancreatitis, pancreatic insufficiency, pancreatic cystic lesions, pancreatic neoplasms, pancreatic surgery, digestive endoscopy, therapeutic endoscopy, colonoscopy, upper gastrointestinal endoscopy, endoscopic ultrasound, ERCP, capsule endoscopy, minimally invasive procedures, laparoscopic surgery, robotic surgery, gastrointestinal imaging, radiology in digestive diseases, histopathology, molecular pathology, biomarkers in gastrointestinal diseases, precision medicine, personalized therapy, translational medicine, regenerative medicine, stem cell therapy, microbiome research, gut microbiota, probiotics, nutrition in gastrointestinal diseases, clinical nutrition, metabolic disorders, obesity and digestive health, bariatric medicine, gastrointestinal genetics, hereditary gastrointestinal disorders, hepatobiliary genetics, pancreatic genetics, molecular diagnostics, genomic medicine, proteomics, metabolomics, bioinformatics, artificial intelligence in gastroenterology, machine learning in digestive disease diagnosis, big data in healthcare, clinical trials, drug discovery, drug development, biologics, immunotherapy, targeted therapy, vaccine development, public health gastroenterology, preventive gastroenterology, epidemiology of digestive diseases, global digestive health, pediatric gastroenterology, geriatric gastroenterology, women’s digestive health, rehabilitation in digestive disorders, palliative care, healthcare management, patient-centered care, medical education, ethics in gastroenterology, legal and social aspects of digestive healthcare, informed consent, healthcare policies, and emerging technologies in digestive and hepatopancreatic research.

Types of Manuscripts

The journal accepts a variety of manuscript types including original research articles, review articles, systematic reviews, meta-analyses, clinical studies, case reports, case series, short communications, technical notes, editorials, perspectives, clinical images, and letters to the editor.

The topics listed above represent the major areas of interest of the journal; however, the scope is not limited to these fields alone. The journal welcomes submissions from emerging, interdisciplinary, and innovative areas that contribute to the understanding, diagnosis, prevention, and treatment of gastrointestinal, liver, and pancreatic diseases.

Global Perspective and Inclusivity

The journal adopts a global perspective by encouraging submissions from researchers and clinicians across diverse geographic regions. Gastrointestinal, liver, and pancreatic diseases affect populations worldwide, with variations in prevalence, presentation, environmental risk factors, lifestyle influences, and healthcare accessibility.

By promoting international collaboration, the journal seeks to address global digestive health challenges and reduce disparities in diagnosis, treatment, and patient care. Studies highlighting regional trends, population-specific findings, healthcare strategies, and public health interventions are particularly encouraged.

Ethical, Legal, and Social Considerations

Research and clinical practice in gastroenterology and hepatopancreatic medicine involve important ethical, legal, and social considerations. The journal recognizes the significance of these issues and encourages scholarly work addressing responsible clinical practice, patient safety, research ethics, and equitable healthcare access.

Topics such as informed consent, patient privacy, ethical clinical trials, healthcare accessibility, organ transplantation ethics, and healthcare policy are integral to the ethical framework of the journal. Authors are expected to adhere to recognized ethical guidelines and maintain integrity and transparency in all submitted work.

Education and Knowledge Dissemination

The journal is committed to advancing education and knowledge dissemination in gastroenterology, hepatology, and pancreatic diseases. It aims to serve as a valuable resource for students, educators, clinicians, researchers, and healthcare professionals by publishing informative, evidence-based, and impactful scientific content.

Educational reviews, clinical updates, practice guidelines, and articles simplifying complex digestive health concepts are strongly encouraged. Through continuous learning and professional development, the journal contributes to building a well-informed scientific and clinical community.

Quality, Integrity, and Scientific Rigor

Maintaining high standards of scientific quality and publication ethics is a core principle of the journal. All submissions are expected to demonstrate methodological soundness, originality, clinical relevance, and clarity of presentation.

The peer review process is designed to ensure unbiased, transparent, and rigorous evaluation of manuscripts. Authors are encouraged to present their findings accurately and responsibly, contributing to the reliability and credibility of scientific literature in digestive healthcare.

Encouragement of Collaborative Research

The journal strongly supports collaborative and multidisciplinary research involving clinicians, surgeons, pathologists, radiologists, nutritionists, molecular scientists, epidemiologists, and public health experts. Collaborative studies often generate more comprehensive insights into complex gastrointestinal and hepatopancreatic disorders.

By providing a platform for interdisciplinary partnerships, the journal aims to foster innovation, improve research quality, and accelerate scientific advancements in digestive medicine.

Adaptability to Advancing Science

The fields of gastroenterology, hepatology, and pancreatic medicine are continuously evolving with advancements in diagnostic technologies, molecular medicine, artificial intelligence, endoscopic procedures, and therapeutic interventions. The journal remains adaptable to these scientific developments by expanding its scope to include emerging research areas and novel healthcare technologies.

Authors are encouraged to explore innovative concepts and contribute to the evolving landscape of digestive health sciences. The journal is committed to reflecting current scientific progress and supporting future advancements in gastrointestinal, liver, and pancreatic disease research.